All In Biotech

Free tool

FAERS Monitor: Belbuca

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207932 or its brand name (Belbuca, Buprenorphine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

7,463

Serious

5,578

75% of reports

Hospitalization

1,117

Death reported

1,051

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dependence2,858
  • overdose1,452
  • death461
  • drug ineffective426
  • ill-defined disorder414
  • nausea352
  • pain330
  • headache309
  • foetal exposure during pregnancy306
  • depression292
  • product adhesion issue276
  • maternal exposure during pregnancy273
  • drug withdrawal syndrome neonatal271
  • off label use268
  • vomiting264

Reports by year received

View as table
YearReports
200476
200514
200619
20074
200833
200921
201032
201125
201226
2013155
201445
201569
2016289
2017138
2018155
2019222
2020264
2021199
2022532
20233,285
2024837
2025711
2026311

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,696 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dependenceSignal2,858155.0150.4415,322
drug withdrawal syndrome neonatalSignal27152.546.713,406
product adhesion issueSignal27621.919.55,460
ill-defined disorderSignal41419.317.67,150
overdoseSignal1,45219.118.224,965
foetal exposure during pregnancySignal30610.69.52,665
maternal exposure during pregnancySignal2738.77.71,843
depressionSignal2923.63.2556
vomiting2641.61.457
pain3301.51.459
death4611.51.482
headache3091.41.234
nausea3521.31.118
drug ineffective4260.90.84
off label use2680.90.86

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.